What's new

RSS
Date Content
30/11/2018 Human medicines European public assessment report (EPAR): irbesartan / hydrochlorothiazide, Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Hypertension, 26/11/2009, 14, Authorised (updated)
30/11/2018 Human medicines European public assessment report (EPAR): umeclidinium bromide / vilanterol, Laventair Ellipta (previously Laventair), umeclidinium bromide / vilanterol, Pulmonary Disease, Chronic Obstructive, 08/05/2014, 9, Authorised (updated)
30/11/2018 Human medicines European public assessment report (EPAR): human normal immunoglobulin, Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic, Bone Marrow Transplantation, Immunologic Deficiency Syndromes, Guillain-Barre Syndrome, Mucocutaneous Lymph Node Syndrome, 18/01/2006, 20, Authorised (updated)
30/11/2018 Agenda: Agenda - COMP agenda of the 4-6 December 2018 meeting
30/11/2018 Human medicines European public assessment report (EPAR): topotecan, Topotecan Hospira, topotecan, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma, 09/06/2010, 13, Authorised (updated)
30/11/2018 Other: Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004
30/11/2018 Other: CVMP assessment report regarding the request for an opinion under Article 30(3) of Regulation (EC) No. 726/2004
30/11/2018 Human medicines European public assessment report (EPAR): mercaptamine, Cystadrops, mercaptamine, Cystinosis, 18/01/2017, 3, Authorised (updated)
30/11/2018 Other: EudraVigilance registration documents (updated)
30/11/2018 Other: Change of qualified person for pharmacovigilance and responsible person for EudraVigilance (updated)